Pathogenesis and Treatment of Acute Exacerbations of Chronic Obstructive Pulmonary Disease

Sanjay Sethi

doi:10.1055/s-2005-869538

Seminars in Respiratory and Critical Care Medicine, Inhaltsverzeichnis

Semin Respir Crit Care Med 2005; 26(2): 192-203
DOI: 10.1055/s-2005-869538

Pathogenesis and Treatment of Acute Exacerbations of Chronic Obstructive Pulmonary Disease

Sanjay Sethi¹ ^, ²

¹Division of Pulmonary and Critical Care Medicine, Department of Medicine, University at Buffalo SUNY, Buffalo, New York
²Department of Veterans Affairs, Western New York Healthcare System, Buffalo, New York

Abstract

ABSTRACT

Once thought to be a mere nuisance, exacerbations are now recognized as a major contributor to the morbidity and mortality associated with chronic obstructive pulmonary disease. This recognition has led to research using new investigative tools that has substantially enhanced our understanding of the pathogenesis of exacerbations. Several overlapping etiologies can precipitate the symptom complex of an exacerbation. Treatment of exacerbations requires the use of several therapeutic modalities with the goal of restoring the patient to baseline. Results of recent clinical trials and observational studies have allowed a refinement of the approach to treatment of exacerbations. These include a rational, stratified approach to the use of antibiotics and several trials substantiating the use of systemic corticosteroids. Relapse or failure rates of 20 to 33% have been described in the treatment of acute exacerbation, with these treatment failures contributing substantially to the costs associated with exacerbations. Improved treatment based on enhanced understanding and good clinical evidence should lead to better outcomes in this common clinical entity.

KEYWORDS

Chronic obstructive pulmonary disease - exacerbation - pathogenesis - antibiotics

Volltext

Referenzen

REFERENCES

1 Mapel D W, Hurley J S, Frost F J, Petersen H V, Picchi M A, Coultas D B. Health care utilization in chronic obstructive pulmonary disease: a case-control study in a health maintenance organization. Arch Intern Med. 2000; 160 2653-2658
2 Fabbri L M, Hurd S S. Global strategy for the diagnosis, management and prevention of COPD: 2003 update. Eur Respir J. 2003; 22 1-2
3 Rodriguez-Roisin R. Toward a consensus definition for COPD exacerbations. Chest. 2000; 117(5 suppl 2) 398S-401S
4 Sethi S, Evans N, Grant B JB, Murphy T F. Acquisition of a new bacterial strain and occurrence of exacerbations of chronic obstructive pulmonary disease. N Engl J Med. 2002; 347 465-471
5 Saetta M, Turato G, Maestrelli P, Mapp C E, Fabbri L M. Cellular and structural bases of chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2001; 163 1304-1309
6 White A J, Gompertz S, Stockley R A. Chronic obstructive pulmonary disease, VI: The aetiology of exacerbations of chronic obstructive pulmonary disease. Thorax. 2003; 58 73-80
7 Sethi S. New developments in the pathogenesis of acute exacerbations of chronic obstructive pulmonary disease. Curr Opin Infect Dis. 2004; 17 113-119
8 Sethi S, Muscarella K, Evans N, Klingman K L, Grant B JB, Murphy T F. Airway inflammation and etiology of acute exacerbations of chronic bronchitis. Chest. 2000; 118 1557-1565
9 Gompertz S, O'Brien C, Bayley D L, Hill S L, Stockley R A. Changes in bronchial inflammation during acute exacerbations of chronic bronchitis. Eur Respir J. 2001; 17 1112-1119
10 Zhu J, Qiu Y S, Majumdar S et al.. Exacerbations of bronchitis: bronchial eosinophilia and gene expression for interleukin-4, interleukin-5, and eosinophil chemoattractants. Am J Respir Crit Care Med. 2001; 164 109-116
11 Balbi B, Bason C, Balleari E et al.. Increased bronchoalveolar grnulocytes and granulocyte-macrophage colony-stimulating factor during exacerbations of chronic bronchitis. Eur Respir J. 1997; 10 846-850
12 Saetta M, Di Stefano A, Maestrelli P et al.. Airway eosinophilia in chronic bronchitis during exacerbations. Am J Respir Crit Care Med. 1994; 150(6 Pt 1) 1646-1652
13 Stockley R A. The role of proteinases in the pathogenesis of chronic bronchits. Am J Respir Crit Care Med. 1994; 150 S109-S113
14 Wouters E F. Chronic obstructive pulmonary disease, V: Systemic effects of COPD. Thorax. 2002; 57 1067-1070
14a Saetta M, Di Stefano A, Maestrelli J P et al.. Airway eosinophilia in chronic bronchitis during exacerbations. Am J Respir Crit Care Med. 1994; 150 1646-1652
14b Crooks S W, Bayley D L, Hill S L, Stockley R A. Bronchial inflammation in acute bacterial exacerbations of chronic bronchitis: the role of leukotriene B4. Eur Respir J. 2000; 15 274-280
14c Biernacki W A, Kharitonov S A, Barnes P J. Increased leukotriene B4 and 8-isoprostane in exhaled breath condensate of patients with exacerbations of COPD. Thorax. 2003; 58 294-298
14d Bhowmik A, Seemungal T A, Sapsford R J, Wedzicha J A. Relation of sputum inflammatory markers to symptoms and lung function changes in COPD exacerbations. Thorax. 2000; 55 114-120
14e Stockley R A, O'Brien C, Pye A, Hill S L. Relationship of sputum color to nature and outpatient management of acute exacerbations of COPD. Chest. 2000; 117 1638-1645
14f Agusti A G, Villaverde J M, Togores B, Bosch M. Serial measurements of exhaled nitric oxide during exacerbations of chronic obstructive pulmonary disease. Eur Respir J. 1999; 14 523-528
14g Roland M, Bhowmik A, Sapsford R J et al.. Sputum and plasma endothelin-1 levels in exacerbations of chronic obstructive pulmonary disease. Thorax. 2001; 56 30-35
15 Wedzicha J A, Seemungal T A, MacCallum P K et al.. Acute exacerbations of chronic obstructive pulmonary disease are accompanied by elevations of plasma fibrinogen and serum IL-6 levels. Thromb Haemost. 2000; 84 210-215
16 Dev D, Wallace E, Sankaran R et al.. Value of C-reactive protein measurements in exacerbations of chronic obstructive pulmonary disease. Respir Med. 1998; 92 664-667
17 Ohtoshi T, Takizawa H, Okazaki H et al.. Diesel exhaust particles stimulate human airway epithelial cells to produce cytokines relevant to airway inflammation in vitro. J Allergy Clin Immunol. 1998; 101 778-785
18 Devalia J L, Rusznak C, Herdman M J, Trigg C J, Tarraf H, Davies R J. Effect of nitrogen dioxide and sulphur dioxide on airway response of mild asthmatic patients to allergen inhalation. Lancet. 1994; 344 1668-1671
19 Rudell B, Blomberg A, Helleday R. Bronchoalveolar inflammation after exposure to diesel exhaust: comparison between unfiltered and particle trap filtered exhaust. Occup Environ Med. 1999; 56 527-534
20 Garcia-Aymerich J, Tobias A, Anto J M, Sunyer J. Air pollution and mortality in a cohort of patients with chronic obstructive pulmonary disease: a time series analysis. J Epidemiol Community Health. 2000; 54 73-74
21 Sunyer J, Saez M, Murillo C, Castellsague J, Martinez F, Anto J M. Air pollution and emergency room admissions for chronic obstructive pulmonary disease: a 5-year study. Am J Epidemiol. 1993; 137 701-705
22 Sunyer J, Schwartz J, Tobias A, Macfarlane D, Garcia J, Anto J M. Patients with chronic obstructive pulmonary disease are at increased risk of death associated with urban particle air pollution: a case-crossover analysis. Am J Epidemiol. 2000; 151 50-56
23 Sethi S. Infectious etiology of acute exacerbations of chronic bronchitis. Chest. 2000; 117 380S-385S
24 Hirschmann J V. Do bacteria cause exacerbations of COPD?. Chest. 2000; 118 193-203
25 Murphy T F, Sethi S, Niederman M S. The role of bacteria in exacerbations of COPD: a constructive view. Chest. 2000; 118 204-209
26 Sethi S, Murphy T F. Bacterial infection in chronic obstructive pulmonary disease in 2000: a state-of-the-art review. Clin Microbiol Rev. 2001; 14 336-363
27 Chastre J, Fagon J-Y, Bornet-Lesco M et al.. Evaluation of bronchoscopic techniques for the diagnosis of nosocomial pneumonia. Am J Respir Crit Care Med. 1995; 152 231-240
28 Monso E, Ruiz J, Rosell A et al.. Bacterial infection in chronic obstructive pulmonary disease: a study of stable and exacerbated outpatients using the protected specimen brush. Am J Respir Crit Care Med. 1995; 152 1316-1320
29 Fagon J-Y, Chastre J, Trouillet J-L et al.. Characterization of distal bronchial microflora during acute exacerbation of chronic bronchitis. Am Rev Respir Dis. 1990; 142 1004-1008
30 Soler N, Torres A, Ewig S et al.. Bronchial microbial patterns in severe exacerbations of chronic obstructive pulmonary disease (COPD) requiring mechanical ventilation. Am J Respir Crit Care Med. 1998; 157 1498-1505
31 Pela R, Marchesani F, Agostinelli C et al.. Airways microbial flora in COPD patients in stable clinical conditions and during exacerbations: a bronchoscopic investigation. Monaldi Arch Chest Dis. 1998; 53 262-267
32 Bandi V, Apicella M A, Mason E et al.. Nontypeable Haemophilus influenzae in the lower respiratory tract of patients with chronic bronchitis. Am J Respir Crit Care Med. 2001; 164 2114-2119
33 Gump D W, Phillips C A, Forsyth B R, McIntosh F K, Lamborn K R, Stouch W H. Role of infection in chronic bronchitis. Am Rev Respir Dis. 1976; 113 465-473
34 McHardy V U, Inglis J M, Calder M A, Crofton J W. A study of infective and other factors in exacerbations of chronic bronchitis. Br J Dis Chest. 1980; 74 228-238
35 Gog J R, Grenfell B T. Dynamics and selection of many-strain pathogens. Proc Natl Acad Sci USA. 2002; 99 17209-17214
36 Sethi S, Wrona C, Grant B, Murphy T. Strain‐specific immune response to Haemophilus influenzae in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2004; 169 448-453
37 Bakri F, Brauer A L, Sethi S, Murphy T F. Systemic and mucosal antibody response to Moraxella catarrhalis following exacerbations of chronic obstructive pulmonary disease. J Infect Dis. 2002; 185 632-640
38 Abe Y, Murphy T F, Sethi S et al.. Lymphocyte proliferative response to P6 of Haemophilus influenzae is associated with relative protection from exacerbations of chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2002; 165 967-971
39 Aaron S D, Angel J B, Lunau M et al.. Granulocyte inflammatory markers and airway infection during acute exacerbation of chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2001; 163 349-355
40 White A J, Gompertz S, Bayley D L et al.. Resolution of bronchial inflammation is related to bacterial eradication following treatment of exacerbations of chronic bronchitis. Thorax. 2003; 58 680-685
41 Rohde G, Wiethege A, Borg I et al.. Respiratory viruses in exacerbations of chronic obstructive pulmonary disease requiring hospitalisation: a case-control study. Thorax. 2003; 58 37-42
42 Tan W C, Xiang X, Qiu D, Ng T P, Lam S F, Hegele R G. Epidemiology of respiratory viruses in patients hospitalized with near-fatal asthma, acute exacerbations of asthma, or chronic obstructive pulmonary disease. Am J Med. 2003; 115 272-277
43 Seemungal T A, Harper-Owen R, Bhowmik A, Jeffries D J, Wedzicha J A. Detection of rhinovirus in induced sputum at exacerbation of chronic obstructive pulmonary disease. Eur Respir J. 2000; 16 677-683
44 Lieberman D, Gelfer Y, Varshavsky R, Dvoskin B, Leinonen M, Friedman M G. Pneumonic vs nonpneumonic acute exacerbations of COPD. Chest. 2002; 122 1264-1270
45 von Hertzen L, Alakarppa H, Koskinen R et al.. Chlamydia pneumoniae infection in patients with chronic obstructive pulmonary disease. Epidemiol Infect. 1997; 118 155-164
46 Blasi F, Damato S, Cosentini R et al.. Chlamydia pneumoniae and chronic bronchitis: association with severity and bacterial clearance following treatment. Thorax. 2002; 57 672-676
47 Lieberman D, Lieberman D, Ben-Yaakov M et al.. Serological evidence of Mycoplasma pneumoniae infection in acute exacerbation of COPD. Diagn Microbiol Infect Dis. 2002; 44 1-6
48 Mogulkoc N, Karakurt S, Isalska B et al.. Acute purulent exacerbation of chronic obstructive pulmonary disease and Chlamydia pneumoniae infection. Am J Respir Crit Care Med. 1999; 160 349-353
49 Miyashita N, Niki Y, Nakajima M, Kawane H, Matsushima T. Chlamydia pneumoniae infections in patients with diffuse panbronchiolitis and COPD. Chest. 1998; 114 969-971
50 Karnak D, Beng-sun S, Beder S, Kayacan O. Chlamydia pneumoniae infection and acute exacerbation of chronic obstructive pulmonary disease (COPD). Respir Med. 2001; 95 811-816
51 Hahn D L, Golubjatnikov R. Smoking is a potential confounder of the Chlamydia pneumoniae-coronary artery disease association. Arterioscler Thromb. 1992; 12 945-947
52 Beaty C D, Grayston J T, Wang S P, Kuo C C, Reto C S, Martin T R. Chlamydia pneumoniae, strain TWAR, infection in patients with chronic obstructive pulmonary disease. Am Rev Respir Dis. 1991; 144 1408-1410
53 Blasi F, Legnani D, Lombardo V M et al.. Chlamydia pneumoniae infection in acute exacerbations of COPD. Eur Respir J. 1993; 6 19-22
54 Smith C B, Golden C, Kanner R, Renzetti Jr A D. Association of viral and Mycoplasma pneumoniae infections with acute respiratory illness in patients with chronic obstructive pulmonary diseases. Am Rev Respir Dis. 1980; 121 225-232
55 Sethi S. Acute exacerbations of COPD: a “multipronged” approach. J Respir Dis. 2002; 23 217-255
56 Bach P B, Brown C, Gelfand S E, McCrory D C. Management of acute exacerbations of chronic obstructive pulmonary disease: a summary and appraisal of published evidence. Ann Intern Med. 2001; 134 600-620
57 Balter M S, La Forge J, Low D E, Mandell L, Grossman R F. Canadian guidelines for the management of acute exacerbations of chronic bronchitis. Can Respir J. 2003; 10(Suppl B) 3B-32B
58 Murphy T F, Sethi S. Chronic obstructive pulmonary disease: role of bacteria and guide to antibacterial selection in the older patient. Drugs Aging. 2002; 19 761-775
59 Saint S, Bent S, Vittinghoff E, Grady D. Antibiotics in chronic obstructive pulmonary disease exacerbations: a meta-analysis. JAMA. 1995; 273 957-996
60 Sachs A PE, Koeter G H, Groenier K H, van der Waaij D, Schiphuis J, Jong B M. Changes in symptoms, peak expiratory flow, and sputum flora during treatment with antibiotics of exacerbations in patients with chronic obstructive pulmonary disease in general practice. Thorax. 1995; 50 758-763
61 Nouira S, Marghli S, Belghith M, Besbes L, Elatrous S, Abroug F. Once-daily oral ofloxacin in chronic obstructive pulmonary disease exacerbation requiring mechanical ventilation: a randomised placebo-controlled trial. Lancet. 2001; 358 2020-2025
62 Allegra L, Blasi F, de Bernardi B, Cosentini R, Tarsia P. Antibiotic treatment and baseline severity of disease in acute exacerbations of chronic bronchitis: a reevaluation of previously published data of a placebo-controlled randomized study. Pulm Pharmacol Ther. 2001; 14 149-155
63 Anthonisen N R, Manfreda J, Warren C PW, Hershfield E S, Harding G KM, Nelson N A. Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease. Ann Intern Med. 1987; 106 196-204
64 Sethi S. Bacteria in exacerbations of chronic obstructive pulmonary disease: phenomenon or epiphenomenon?. Proc Am Thorac Soc.. 2004; 1 109-114
65 Wilson R, Schentag J J, Ball P, Mandell L. A comparison of gemifloxacin and clarithromycin in acute exacerbations of chronic bronchitis and long-term clinical outcomes. Clin Ther. 2002; 24 639-652
66 Spencer S, Jones P W. Time course of recovery of health status following an infective exacerbation of chronic bronchitis. Thorax. 2003; 58 589-593
67 Wilson R, Allegra L, Huchon G et al.. Short-term and long-term outcomes of moxifloxacin compared to standard antibiotic treatment in acute exacerbations of chronic bronchitis. Chest. 2004; 125 953-964
68 Ball P, Harris J M, Lowson D, Tillotson G, Wilson R. Acute infective exacerbations of chronic bronchitis. Q J Med. 1995; 88 61-68
69 Dewan N A, Rafique S, Kanwar B et al.. Acute exacerbation of COPD: factors associated with poor treatment outcome. Chest. 2000; 117 662-671
70 Miravitlles M, Murio C, Guerrero T. Factors associated with relapse after ambulatory treatment of acute exacerbations of chronic bronchitis. DAFNE Study Group. Eur Respir J. 2001; 17 928-933
71 Groenewegen K H, Schols A M, Wouters E F. Mortality and mortality-related factors after hospitalization for acute exacerbation of COPD. Chest. 2003; 124 459-467
72 Adams S G, Melo J, Luther M, Anzueto A. Antibiotics are associated with lower relapse rates in outpatients with acute exacerbations of COPD. Chest. 2000; 117 1345-1352

Sanjay SethiM.D

VA WNY Healthcare System (151)

3495 Bailey Ave., Buffalo, NY 14215

eMail: ssethi@buffalo.edu